Jane Street’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-13,750
Closed -$1.1M 10823
2021
Q1
$1.1M Sell
13,750
-6,427
-32% -$502K ﹤0.01% 5278
2020
Q4
$1.59M Sell
20,177
-44,116
-69% -$2.59M ﹤0.01% 3917
2020
Q3
$2.83M Buy
64,293
+55,153
+603% +$2.72M ﹤0.01% 2521
2020
Q2
$404K Buy
+9,140
New +$341K ﹤0.01% 5391
2019
Q4
Sell
-4,285
Closed -$321K 6042
2019
Q3
$321K Buy
+4,285
New +$363K ﹤0.01% 4098
2018
Q3
Sell
-74,114
Closed -$7.29M 5951
2018
Q2
$7.29M Buy
+74,114
New +$8.29M 0.02% 785
2017
Q3
Sell
-7,782
Closed -$606K 5271
2017
Q2
$606K Buy
7,782
+3,769
+94% +$283K ﹤0.01% 2775
2017
Q1
$321K Buy
+4,013
New +$319K ﹤0.01% 3354
2016
Q4
Sell
-9,304
Closed -$726K 4807
2016
Q3
$726K Buy
+9,304
New +$675K ﹤0.01% 2343
2016
Q2
Sell
-3,481
Closed -$248K 4781
2016
Q1
$248K Buy
+3,481
New +$219K ﹤0.01% 3437
2014
Q1
Sell
-10,952
Closed -$371K 3192
2013
Q4
$371K Buy
+10,952
New +$379K 0.01% 1473

Jane Street's CMD Position: Q2 2021 in Review

Jane Street sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 13,750 shares — an estimated $1.1M sold.

Jane Street first reported a position in CMD in Q4 2013 and held it in 11 quarters. The position peaked at $7.29M in Q2 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

  • Jane Street reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • Jane Street sold 13,750 Cantel Medical Corporation shares in Q2 2021, an estimated $1.1M.
  • Jane Street first reported a position in Cantel Medical Corporation in Q4 2013 and held it in 11 quarters.
  • Jane Street's Cantel Medical Corporation position peaked at $7.29M in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Jane Street's 13F filing for Q2 2021, filed 16 Aug 2021.